COMMUNIQUÉS West-GlobeNewswire

AIT Granted New Patent for Its Nitric Oxide (NO) Generator and Delivery System
29/03/2018
Patent covers technology for a disposable that filters nitrogen dioxide (NO2) gas and programs the system for use NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical [...]
Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthenic Syndrome
29/03/2018
CORAL GABLES, Fla., March 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update
29/03/2018
NORCROSS, Ga., March 29, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today reported financial results for the year ended [...]
Novan Announces Corporate Update Conference Call and Webcast
29/03/2018
MORRISVILLE, N.C., March 29, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN ) today announced that the Company will host a conference call on Thursday, April 12, at 8:30 a.m. Eastern Time [...]
NSVRC Kicks Off the 17th Annual Sexual Assault Awareness Month with “Embrace Your Voice” Theme
29/03/2018
Harrisburg, PA, March 29, 2018 (GLOBE NEWSWIRE) -- Building on the powerful voices that have emerged following the #MeToo and Time’s Up movements, the National Sexual Violence Resource Center (NSVRC) is proud to launch [...]
Emblem Signs Key Supplier Agreement with Shoppers Drug Mart
29/03/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the “Company”) , has [...]
Bio-Path Holdings Announces Publication in The Lancet Haematology
29/03/2018
HOUSTON, March 29, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Spectral Announces Fourth Quarter and Fiscal 2017 Results
29/03/2018
TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]
Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC
29/03/2018
ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product (QIDP) BRIDGEWATER, N.J., March 29, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global [...]
Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia
29/03/2018
NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that a comparative summary [...]
CareDx Announces Completion of Debt Conversion
29/03/2018
BRISBANE, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Onsite Health Diagnostics is the first to successfully complete CLIA-Waived Laboratory Regulatory Compliance Audit performed by eTrueNorth
29/03/2018
DALLAS, March 29, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S. based healthcare technology & compliance solution provider for CLIA-waived laboratories, is the only provider that certifies regulatory compliance in [...]
Tyme Technologies, Inc. Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018
29/03/2018
NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that it will be featured as a presenting company at the H. C. Wainwright Annual Global Life [...]
Jeff Arnold and Dr. Mehmet Oz to Join Governor Nathan Deal for Announcement about Improving Health of Georgia Residents
29/03/2018
ATLANTA, March 29, 2018 (GLOBE NEWSWIRE) -- Jeff Arnold and Dr. Mehmet Oz, co-founders of Sharecare, the digital health company helping people manage all their health in one place, will join Georgia Governor Nathan Deal [...]
New Published Clinical Trial Confirms NIAGEN® Supplementation Raised Nicotinamide Adenine Dinucleotide (NAD) Levels and Potentially Improves Blood Pressure and Cardiovascular Health
29/03/2018
IRVINE, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that results from a human [...]
Evolus Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018
IRVINE, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus” or the “Company”), a medical aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians [...]
Auris Regains Compliance with Nasdaq's Minimum Bid Price Requirement
29/03/2018
Zug, Switzerland, March 29, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced it [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
29/03/2018
FIT Biotech Oy Company release March 29, 2018 at 01:30 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech Oy [...]
MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence
29/03/2018
LA JOLLA, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Pages